Ali Alrefai

456 total citations
11 papers, 355 citations indexed

About

Ali Alrefai is a scholar working on Neurology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Ali Alrefai has authored 11 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Ali Alrefai's work include Botulinum Toxin and Related Neurological Disorders (2 papers), Multiple Sclerosis Research Studies (2 papers) and Neurological disorders and treatments (2 papers). Ali Alrefai is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (2 papers), Multiple Sclerosis Research Studies (2 papers) and Neurological disorders and treatments (2 papers). Ali Alrefai collaborates with scholars based in Jordan, United States and Ireland. Ali Alrefai's co-authors include Yousef Khader, Khalid El‐Salem, Mya C. Schiess, Ashley J. Hood, Anne B. Sereno, Kevin A. Briand, Kefah Al‐Hayk, Stacy A. Rudnicki, Taiseer Hussain Al-Khateeb and Zouhair Amarin and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Medicine and Muscle & Nerve.

In The Last Decade

Ali Alrefai

10 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Alrefai Jordan 6 168 106 61 50 39 11 355
Juan Manuel Racosta Canada 11 157 0.9× 145 1.4× 41 0.7× 26 0.5× 42 1.1× 21 428
Glen Pollock United States 11 117 0.7× 85 0.8× 107 1.8× 19 0.4× 55 1.4× 15 292
Stefania Bianchi Marzoli Italy 12 194 1.2× 139 1.3× 110 1.8× 31 0.6× 31 0.8× 38 570
F. Rossi Italy 10 64 0.4× 93 0.9× 40 0.7× 18 0.4× 41 1.1× 17 278
Lin Qiao China 13 103 0.6× 91 0.9× 46 0.8× 37 0.7× 73 1.9× 35 391
Susan Shin United States 9 194 1.2× 49 0.5× 45 0.7× 34 0.7× 41 1.1× 31 438
Margherita Simonetta Italy 10 128 0.8× 38 0.4× 31 0.5× 66 1.3× 37 0.9× 19 479
Carolina de Medeiros Rimkus Brazil 11 78 0.5× 173 1.6× 35 0.6× 36 0.7× 11 0.3× 37 299
Frank Hoffmann Germany 12 120 0.7× 240 2.3× 73 1.2× 12 0.2× 26 0.7× 31 450
A. Gordon Smith United States 12 242 1.4× 43 0.4× 76 1.2× 18 0.4× 70 1.8× 27 506

Countries citing papers authored by Ali Alrefai

Since Specialization
Citations

This map shows the geographic impact of Ali Alrefai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Alrefai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Alrefai more than expected).

Fields of papers citing papers by Ali Alrefai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Alrefai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Alrefai. The network helps show where Ali Alrefai may publish in the future.

Co-authorship network of co-authors of Ali Alrefai

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Alrefai. A scholar is included among the top collaborators of Ali Alrefai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Alrefai. Ali Alrefai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Alrefai, Ali, et al.. (2024). Pleomorphic adenoma of hard palate: Review of updated literature and “case report”. Medicine. 103(36). e39529–e39529.
2.
Alrefai, Ali, et al.. (2015). Early onset multiple sclerosis in Jordan: A retrospective analysis. Journal of Pediatric Neurology. 4(3). 155–160. 3 indexed citations
3.
Alrefai, Ali, et al.. (2012). Against all odds: surviving rhino–orbital–cerebral mucormycosis: a case report. Journal of NeuroVirology. 18(2). 144–147. 3 indexed citations
4.
El‐Salem, Khalid, et al.. (2012). Interval Neurophysiological Changes in Non Septic Critically Ill Mechanically Ventilated Patients. Journal of Clinical Neurophysiology. 29(4). 349–352. 2 indexed citations
5.
El‐Salem, Khalid, et al.. (2011). Prevalence and risk factors of muscle complications secondary to statins. Muscle & Nerve. 44(6). 877–881. 64 indexed citations
6.
Alrefai, Ali, et al.. (2009). Prevalence of Parkinson's disease in Northern Jordan. Clinical Neurology and Neurosurgery. 111(10). 812–815. 11 indexed citations
7.
Alrefai, Ali, et al.. (2009). A case report of cranial polyneuropathy in Behcet’s disease. Neurological Sciences. 31(1). 83–85. 4 indexed citations
8.
Al-Khateeb, Taiseer Hussain, et al.. (2009). Botulinum Toxin A Injections for the Treatment of Schwartz-Jampel Syndrome: A Case Series. Journal of Child Neurology. 24(1). 5–8. 6 indexed citations
9.
Alrefai, Ali, et al.. (2008). Treatment of sialorrhea in children with Cerebral Palsy: A double-blind placebo controlled trial. Clinical Neurology and Neurosurgery. 111(1). 79–82. 51 indexed citations
10.
Hood, Ashley J., et al.. (2006). Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 78(6). 565–570. 122 indexed citations
11.
El‐Salem, Khalid, et al.. (2006). Multiple sclerosis in Jordan: a clinical and epidemiological study. Journal of Neurology. 253(9). 1210–1216. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026